← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nirogyone Therapeutics, Llc
Framingham, MA
$2,792,210
Total funding
3
Grants
Funding over time
peak $1.1M · FY2017–21$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,792,210 · 3
By mechanism
R44$2,000,000 · 1
R43$792,210 · 2
Investigators at Nirogyone Therapeutics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer$1,145,470
R44 · FY2020 · CA
Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer$854,530
R44 · FY2021 · CA
INHIBITORS OF CELLULAR TRANSPORTERS FOR THE TREATMENT OF TNBC$300,000
R43 · FY2017 · CA
TUMOR AND IMMUNO-METABOLISM BASED LACTATE TRANSPORTER INHIBITORs FOR METASTATIC MELANOMA$292,210
R43 · FY2019 · CA
INHIBITORS OF CELLULAR TRANSPORTERS FOR THE TREATMENT OF TNBC$150,000
R43 · FY2018 · CA
INHIBITORS OF CELLULAR TRANSPORTERS FOR THE TREATMENT OF TNBC$50,000
R43 · FY2018 · CA